Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vivimed Labs Ltd. Audit Report / Information 2023

May 22, 2023

61575_rns_2023-05-22_331923c3-5f2f-4cf1-8e95-2a7aa1369862.pdf

Audit Report / Information

Open in viewer

Opens in your device viewer

Date: 22.05.2023

To BSE Limited P.J.Towers, Dalal Street, Mumbai — 400001 BSE - Code : 532660

National Stock Exchange of India Ltd. Exchange Plaza,Plot no. C/1, G Block, Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 NSE- Symbol: VIVIMEDLAB

Dear Sir / Madam,

Sub: Secretarial Compliance Report for the year ended 31% March, 2023

Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/27/2019 dated 8% February, 2019 please find enclosed herewith the Annual Secretarial Compliance Report dated May 20, 2023 issued by Mr.N.V.S.S.Suryanarayana Rao M/s.N.V.S.S.Suryanarayana Rao, Practicing Company Secretary (ACS No.5868 & CP No.2886) Secretarial Auditor of the Company for the financial year ended 31° March, 2023.

Kindly take the same on record and display the same on the website of your exchange.

Vivimedl ib

*/

Thanking you Yours Truly, For Vivimed Labs Limited

K.Yugandhar ve Val FNS

Company Secretary

Enct:a/a

Corporate Office:

NCC House, 4th Floor (Western Wing), Sy. No.64, Madhapur, Hyderabad, Telangana — 500 081, India. GSTIN: 36AAACV6060A12Q T +91 (0) 40-6608-6608, F +91(0) 40-6608-6699

N.V.S.S. SURYANARAYANA RAO Mobile: 9849567451.

B.Com, A.C.S.

COMPANY SECRETARY IN PRACTICE

Annual Secretarial Compliance Report of M/s.Vivimed Labs Limited for the financial year ended 31* March, 2023 (CIN: L02411KA1988PLC009465)

Registered Office: Plot No. 78-A,Kolhar Industrial Area, Bidar, Karnataka. India — 585403

I, N.V.S.S.Suryanarayana Rao, Practicing Company Secretary (ACS No.5868 & CP No.2886) have examined:

  • (a) all the documents and records made available to us and explanation provided by M/s.Vivimed Labs Limited
  • (b) the filings/ submissions made by the listed entity to the stock exchanges,
  • (c) website of the Company,
  • (d) any other document/ filing, as may be relevant, which has been relied upon to make this certification,

for the year ended 31' March, 2023 in respect of compliance with the provisions of :

  • (a) the Securities and Exchange Board of India Act, 1992 ("SEBI Act") and the Regulations, circulars, guidelines issued thereunder; and
  • (b) the Securities Contracts (Regulation) Act, 1956 ("SCRA"), rules made thereunder and the Regulations, circulars, guidelines issued thereunder by the Securities and Exchange Board of India ("SEBI");

The specific Regulations, whose provisions and the circulars/ guidelines issued thereunder, have been examined, include:-

  • (a) Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015;
  • (b) Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018 : Not Applicable during the year under review
  • (c) Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011;
  • (d) Securities and Exchange Board of India (Buyback of Securities) Regulations, 2018; : Not Applicable during the year under review
  • (e) Securities and Exchange Board of India (Share based employee benefits and Sweat Equity) Regulations, 2021;

Office: Plot No.232 B, Road No.6, Samathapuri Colony, New Nagole, Hyderabad - 500 035. [email protected]

  • (f) Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities) Regulations, 2021; Not Applicable during the year under review
  • (g) Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015;
  • (h) Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018;
(f) Securities and Exchange Board of India (Issue and Listing of Non-Convertible Securities)
Regulations, 2021; Not Applicable during the year under review
(g) Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015;
(h) Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018;
and based on the above examination, I/We hereby report that, during the Review Period:
Sr.No. Particulars Compliance
Status
Observations/
Remarks by
Secretarial Standards: (Yes/NO/NA) PCS
compliances
The
entity
of
the
listed
are
in
accordance
applicable
with
Secretarial
the
Standards (SS) issued by the Institute of Company
Secretaries India (ICSI)
Yes
Adoption and timely updation of the Policies:
* All applicable policies under SEBI Regulations
are adopted with the approval of board of directors
of the listed entities
Yes
SEBI
conformity with
the policies
All
are
in
¢
reviewed
Regulations
been
and
&
timely
has
updated
regulations/
circulars/
per
the
as
guidelines issued by SEBI
Yes
Maintenance and disclosures on Website:
maintaining
The
functional
Listed
entity
a
is
*
website
Yes
Timely
documents/
dissemination
of
the
¢
information under a separate section on the
Website
Yes
Web-links
provided
annual
corporate
in
¢
governance
Regulation
under
reports
27(2)
are
which
accurate
and
specific
re-directs
the
to
Yes
relevant document(s) section of the website
Disqualification of Director:
Company
None
Director
of
the
of
the
are
disqualified under Section 164 of Companies Act,
2013
Yes
examine
Subsidiaries
To
related
details
of
to
listed entities:
a. Identification of material subsidiary companies
Requirements
disclosure
with
respect
of
to
b.
Yes
6 Preservation of Documents:
The listed entity is preserving and maintaining
records as prescribed under SEBI Regulations and
disposal of records as per Policy of Preservation of
Documents and Archival policy prescribed under
SEBI LODR Regulations, 2015.
Yes
$\overline{7}$ Performance Evaluation:
The listed entity has conducted performance
evaluation of the Board, Independent Directors and
the Committees at the start of every financial year
as prescribed in SEBI Regulations
Yes
8 Related Party Transactions:
a. The listed entity has obtained prior approval of
Audit Committee for all Related party transactions
b. In case no prior approval obtained, the listed
Yes All RPT Taken
Prior Approval
entity shall provide detailed reasons along with
confirmation whether the transactions were
subsequently approved /ratified /rejected by the
Audit committee
NA
9 Disclosure of events or information:
The listed entity has provided all the required
disclosure(s) under Regulation 30 along with
Schedule III of SEBI LODR Regulations, 2015
within the time limits prescribed thereunder.
Yes
10 Prohibition of Insider Trading:
The listed entity is in compliance with Regulation
$3(5)$ & $3(6)$ SEBI (Prohibition of Insider Trading)
Regulations, 2015
Yes
11 Actions taken by SEBI or Stock Exchange(s), if
any:
Actions taken against the listed entity/ its
promoters/directors/ subsidiaries either by SEBI
or by Stock Exchanges (including under the
Standard Operating Procedures issued by SEBI
through various circulars) under SEBI Regulations
and circulars/ guidelines issued thereunder
No Details
provided
in
Point No $12(a)$
below:
12 Additional Non-compliances, if any:
additional non-compliance observed for all SEBI
regulation/circular/guidance note etc.
No Please
refer
$12(a)$ below:
3 2 1 no
Sr.
SEB
I
20
(L
15
OD
R)
SEB
I
20
(L
15
OD
R)
SEB
I
20
(L
15
OD
R)

(R
Re
Co
/g
in
eg
cir
qu
spe
ui
mp
cla
cl
ul
ir
de
cul
li
cif
ud
use
at
li
em
an
in
ars
io
ic
)
ne
en
ce
g
ns
s
t
/
14 34 33
Ci
Re
rc
gu
ul
la
ar
ti
N
on
o.
/
The
lis
not
c
tin
p
g
om
aid
fee
pa
A
t
ny
nn
ot
ua
he
has
l
wit
An
No
FY
nu
h
n-
al
20
in
su
R
21
tim
bm
pre
&
ep
e
is
scr
F
or
si
t
Y22
ibe
on
for
d
for
fin
De
Qu
anc
la
ar
the
y
te
ial
F
r/
in
r
Y
Y
fil
esu
ea
20
ing
lts
r
22
De
vi
at
io
ns

NS
BS
&
E
E
NS
BS
&
E
E
NS
BS
&
E
E
Ta
Ac
by
ke
ti
n
o
n
su
sp
lea
It
en
ma
d
si
y
to
on
pr
pe
Fr
om
na
sha
ee
SO
lt
ot
of
res
zi
P
y
er
ng
s
&
pe
SO
na
lt
P
y

Ac
Ty
ti
pe
on
o
f
lis
Not
tin
p
g
aid
tim
fee
A
w
e
nn
ith
ua
i
l
n

wit
An
No
FY
nu
h
n-
al
20
in
su
21
tim
bm
pre
Re
&
e
is
po
scr
F
rt
si
Y22
ibe
f
on
or
d
thi
wit
pr
No
fin
s
Qu
es
hin
the
n-
anc
ar
reg
cr
su
F
t
te
ial
ib
ula
bm
Y
r/
ed
he
r
tio
is
Y
20
u
esu
per
si
22
n
ear
nd
lts
on
iod
er
for
De
Vi
ta
ol
il
at
s
io
n
of
An
fee
nu
am
f
al
ou
or
l
nt
ist
BSE
ing
Rs
.1
6,
87
-
,0
22
/
Rs
.5
00
0/
-
Fin
e
Am
ou
nt
No
t
pa
id
pa
pai
ym
Par
en
d
t
t
Fin
e
pai
d
O
Pr
Co
Se
Re
bs
ac
cr
of
er
mp
ns
ma
ti
et
va
/
the
rk
an
ci
ar
ti
s
ng
y
y
o
co
wil
mp
Th
l
e
an
pa
y
y
Re
su
FY
co
An
po
bm
20
20
mp
Th
nu
rt
it
23
22
an
e
al
s
te
-
y
d
in
te
Du
iss
ch
e
ni
ues
ca
to
l

Ma
Re
sp
na
ent
on
ge
se
m
- - - Re
ma
rk
s

(a) The listed entity has complied with the provisions of the above regulations and circulars/ guidelines issued thereunder, except in respect n:atters specified below:-

of

The

Additional

disclosures

of

Annual

Secretarial

Compliance

Report

as

below:-

20
15
SEB
Ag
a
I
re
nd
em
(L
OD
en
lis
R)
t
tin
g
MD
SE
Ja
Cir
/C
BI
/12
nu
IR
/H
cul
20
d
ar
/P
O/
ar
20
y
ate
CF
/2
No.
22,
d
D/
02
C
0
wit
09
30(
no.
reg
md
4(1
ag
reg
4(1
reg
20
wit
30(
and
of
/0
h
cir
9)
/4
re
)(e
cir
ula
dat
15
)(d
wi
(lo
ula
ula
h
6)
9/
lis
cla
cul
/2
em
)
th
/cf
tio
)
ed
dr)
of
rea
tio
tio
20
seb
tin
rea
01
en
ar
use
and
rea
d/c
and
ns,
seb
15
d
i
g
ns
ns
5
t
d
d
i
2


/C
SE
Cir
MD
BI
20
cul
/C
/H
20
ar
/1
IR
O/
2
/P
CF
No.
D
/
ma
dis
rai
dis
ex
ki
reg
sin
clo
clo
sub
ch
not
ng
st
ard
g
sur
an
sid
sur
ep
act
in
ge
ma
e
do
iar
e
to
ivi
ad
s
ki
to
wn
an
ies
eq
fun
ng
tie
wit
d/
sto
ua
s
d
h
or
te
ck
in

wit
An
No
FY
nu
h
n-
al
20
in
su
R
21
tim
pr
bm
ep
e
es
is
&
or
cr
si
FY2
t
ib
on
2
ed
for
for
sto
t
ck
he
202
Ex
FY
ch
3
an
20
22
ge
-
s
SE
BI
BSE
NSE
&
Pe
na
lt
y

su
of
in
sp
tra
sha
en
din
si
res
on
g
of
in
tr
sha
ad
res
in
g
ma
dis
rai
dis
ex
ki
reg
sin
clo
sub
clo
ch
ng
not
st
ard
g
sur
an
sur
sid
ep
act
in
ge
ma
e
do
iar
e
to
ivi
ad
s
ki
to
wn
an
ies
eq
fun
ng
tie
wit
d/
sto
ua
s
d
h
or
te
ck
in

wit
An
No
FY
nu
h
n-
al
20
in
su
R
21
bm
pre
ep
is
&
scr
or
si
FY2
t
ibe
on
2
for
d
Rs
.5
,0
0,
00
0/
-

Rs
.1
6,
87
,0
22
/-
Rs
Rs
NSE
.3
.3
.0
a
,5
6,
4,
mo
80
00
un
0/
0/
-
t
-
&
Pa
id
pa
ym
pai
Par
en
d
t
t
- su
Re
co
FY
An
bm
po
20
mp
20
The
nu
rt
it
23
22
an
al
s
te
-
y
d
in
the
fee
lis
tin
g
2015
SEBI
(10DR)
Sr. no
(Regulations/
Requirement
Compliance
guidelines
including
circulars/
specific
clause)
The listed entity has taken the following actions to comply with the observations made in previous reports:
(NVSS SURYANARAYANA RAO)
PRACTICING COMPANY SECRETARY
C.P.NO. 2886
ACS NO. 5868
34 Regulation/
Circular
No.
submission
prescribed
Report for
FY 2021
with in
Annual
time
Non-
Deviations
practicing BSE &
NSE
Action
Taken
$\mathcal{S}$
Compan
Vdefabec
VIElang
penalty
SOP
${\rm Type~of}$
Action
submission
prescribed
Report for
with in
FY 2021
Annual
Non-
Details of
Violation
Rs.2,21,000 Amount
Fine
pied the Practicing
Observations/
Remarks of
Secretary
Company
Report for FY
FY2022-2023
The company
submitted
2021 in
Annual
Management
Response
ı Remarks